Method, device, and kit for population screening for cancer, cancer recurrence and precancerous conditions in symptom free individuals
OwnerAbulKalam Mohammed Shamsuddin, Kim Vanderlindeninventors
Life of this patent
Estimating the term…
Loading patent…
OwnerAbulKalam Mohammed Shamsuddin, Kim Vanderlindeninventors
Estimating the term…
This disclosure relates to a screening test method, device, and kit for carbohydrates found in a biological sample and associated conditions including, cancerous and precancerous conditions. Specifically, the method tests abnormal carbohydrates in a biological sample using reagents of galactose oxidase, and Schiff's Reagent. The screening test method, device, and kit provides expanded testing capabilities across a range of known conditions and in an otherwise healthy population. This disclosure further relates to the use of the device or kit for an initial evaluation for cancerous and precancerous conditions in people without obvious signs and symptoms, and cancer recurrence in at point-of-care facility or at home.
A screening method for rapidly testing a subject for a cancerous or precancerous condition, wherein the subject displays no obvious signs or symptoms of a cancerous or precancerous condition, the method comprising the steps of (a) obtaining a biological sample from an individual;
A method for screening for a cancerous or precancerous condition in an organ other than the large intestine of a human being, wherein the human being displays no obvious signs or symptoms of a cancerous or precancerous condition, the method comprising subjecting a sample of proteinaceous secretion or proteinaceous fluid other than rectal mucus associated with that organ, to an assay for the presence therein of a marker carbohydrate selected from the group consisting of beta-D-Gal-(1->3)-D-GalNAc, Fuc-alpha-1->2 Gal-Beta(1->4)-Fuc-alpha-1->3-G1cNAc, Fuc-Alpha-1->2 Gal-beta-(1->4)-Fuc-alpha-1->3-G1cNAc-beta-(1->3)-Gal-beta-(1->4)-G1cNAc and Fuc-alpha-1->2-Gal-beta-(1->4)-Fuc-alpha-1->3-G1cNAc-beta-(1->3)-Gal-beta-(1->4)-Fuc-alpha-1->3-G1cNAc.
Dependencies are inferred from the claim text.